AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2017
Apr 19, 2017
35021_dirs_2017-04-18_f1445c5d-5625-4b35-af4a-2a8edf225c12.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2017-04-17
Reporting Person: Friend John E. II (VP, Chief Medical Officer)
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 29
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4